Form 4 · Filed May 19, 2026, 09:54 PM UTC
RXRX/RECURSION PHARMACEUTICALS, INC.
Gibson Christopher — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 15, 2026 | F | other | 22,821 | $3 | $69,376 | 883,735 |
Source: SEC EDGAR raw filing ↗ · Accession 0001856369-26-000017